Ms. Marie-Laure Pochon is a Director General at Financière Erasis SAS, an Independent Director at Vexim SA, an Independent Director at Synlab Labco SA, a Chief Executive Officer at Acteon Group, a Chief Executive Officer at Financière Acteon SAS, a Chairman at Acteon India Pvt Ltd., a Chairman at Acteon, Inc., a Chairman at De Gotzen SRL, a Chairman at Produits Dentaires Pierre Rolland, a Chairman at Satelec India Pvt Ltd., a Chief Executive Officer at Acteon SA, an Independent Director at Biom'Up SA, a Manager at Acteon Germany GmbH, a Manager at Apicea SARL, a Manager at Labophare SARL, a Manager at Mlpo SARL, a Manager at Quipoc and a Member-Executive Board at European Federation of Pharmaceutical Industries & Assns.
She is on the Board of Directors at Vexim SA, Synlab Labco SA, Acteon (Thailand) Ltd., Fondation Concorde, Mariepoc, Satelec UK and Biom'Up SA. Ms. Pochon was previously employed as a Senior VP Europe & Worldwide Strategic Accounts by GN Store Nord A/S, an Executive Vice President-Commercial Operations by H. Lundbeck A/S, a Chairman & Chief Executive Officer by Lundbeck SAS, a Chairman by Cercle De Réflexion De L’Industrie Pharmaceutique, a Chairman & Chief Executive Officer by Laboratoires Schwarz Pharma, a Director-Marketing & Product Manager by Merck & Co., Inc., a Chairman by GN Hearing SAS, a Managing Director by SCHWARZ PHARMA, Inc., and a Chairman by Sopro SA.
She also served on the board at Mauna Kea Technologies SA and Leem.
She received her undergraduate degree from École des Hautes Études Commerciales de Paris, an MBA from the Institut Supérieur des Affaires and an MBA from École des Hautes Études Commerciales de Paris.